CLINICAL_TRIALS
trial_result
· 2011-05-17
Clinical Trial Update: A Study of the Safety and Effectiveness of Infliximab (Remicade) in Patients With Giant Cell Arteritis [Phase 2]
Summary
A Phase 2 clinical trial evaluating infliximab (Remicade) for safety and effectiveness in giant cell arteritis has been terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Centocor, Inc. | Conditions: Giant Cell Arteritis | Phase 2 | Status: TERMINATED